Siemens Healthcare

Urology FDA approvals of 2016Urology-related FDA approvals from 2016 encompassed drugs and devices for prostate cancer, renal cell carcinoma, bladder cancer, stone disease, and more.
Uro Pipeline: 1st patients treated in phase III study of investigational BPH TxOther pipeline products discussed in this article include an immunotherapy for metastatic bladder cancer, a treatment for lower urinary tract symptoms of BPH, and an investigational clear cell renal cell carcinoma treatment.
November 2014 New Products: Wearable coil facilitates positioning during prostate MRIOther products featured include a 16-slice CT scanner, new generic testosterone gel, prostate cancer risk calculator, and more.